...
首页> 外文期刊>International Journal of Clinical and Experimental Pathology >Over-expression of p53, p21 and Cdc2 in histologically negative surgical margins is correlated with local recurrence of laryngeal squamous cell carcinoma
【24h】

Over-expression of p53, p21 and Cdc2 in histologically negative surgical margins is correlated with local recurrence of laryngeal squamous cell carcinoma

机译:组织学阴性的切缘中p53,p21和Cdc2的过表达与喉鳞状细胞癌的局部复发有关

获取原文

摘要

The aim of this study was to explore the relationship between the expression of p53, p21 and Cdc2 in the early laryngeal cancer with negative pathological margins and its local recurrence. During 2004-2010, a total of 85 patients with early laryngeal cancer were selected in Tangshan Union Hospital, Hebei, China, and immunohistochemical method was used to detect the expression of p53, p21 and Cdc2 in the negative pathological margin tissues. All patients were followed up for two years to collect pathological data for evaluating the survival and tumor recurrence. Two years after surgery 14 of 85 patients with laryngeal cancer presented with recurrence (recurrent group), while 71 patients without recurrence (none recurrent group). The positive rate of p53, p21 and Cdc2 protein in laryngeal cancer tissues was 60.0% (51/85), 38.8% (33/85) and 70.6% (60/85), respectively, while that of the three proteins in the cancer adjacent tissues was 36.5% (31/85), 21.2% (18/85) and 29.4% (25/85), respectively. The differentiation and TNM stage of tumor had no correlation with the three proteins. The positive rate of p53 in the surgical margin of the recurrent group and non recurrent group was 71.4% (10/14) and 29.6% (21/71) (P = 0.003), that of p21 was 50.0% (7/14) and 15.5% (11/71), (P = 0.011) and Cdc2 was 57.1% (8/14) and 23.9% (17/71) (P = 0.030), respectively. In conclusion, p53, p21 and Cdc2 may be involved in the occurrence, development and recurrence of laryngeal squamous cell carcinoma. Overexpression of p53, p21 and Cdc2 in the surgical margin of early laryngeal cancer is closely related to local recurrence of tumor.
机译:本研究的目的是探讨病理阴性为阴性的早期喉癌中p53,p21和Cdc2的表达与其局部复发之间的关系。 2004-2010年,在河北省唐山协和医院选择了85例早期喉癌患者,并采用免疫组织化学方法检测了阴性病理边缘组织中p53,p21和Cdc2的表达。对所有患者进行了为期两年的随访,以收集病理数据以评估其生存率和肿瘤复发。术后两年,85例喉癌患者中有14例复发(复发组),71例无复发(无复发组)。喉癌组织中p53,p21和Cdc2蛋白的阳性率分别为60.0%(51/85),38.8%(33/85)和70.6%(60/85),而三种蛋白在癌症中的阳性率相邻组织分别为36.5%(31/85),21.2%(18/85)和29.4%(25/85)。肿瘤的分化和TNM分期与这三种蛋白无关。复发组和非复发组手术切缘中p53阳性率分别为71.4%(10/14)和29.6%(21/71)(P = 0.003),p21为50.0%(7/14)和15.5%(11/71),(P = 0.011)和Cdc2分别为57.1%(8/14)和23.9%(17/71)(P = 0.030)。总之,p53,p21和Cdc2可能与喉鳞状细胞癌的发生,发展和复发有关。早期喉癌手术切缘中p53,p21和Cdc2的过度表达与肿瘤的局部复发密切相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号